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The rate of cell-cycle progression must be tuned in
response to nutrient levels to ensure that sufficient
materials are synthesized to generate viable daugh-
ters. We report that accumulation of the yeast M
phase B-cyclin CLB2 mRNA depends on assembly
and activation of the heterogeneous nuclear RNA-
binding protein (hnRNP) arginine methyltransferase
Hmt1, which is promoted by the kinase Dbf2 and
countered by the PP2A phosphatase Pph22. Acti-
vated Hmt1 methylates hnRNPs, which in turn stabi-
lize CLB2 transcripts. Dbf2 activation of Hmt1 is
highly cooperative, producing a sharp increase in
CLB2, whereas Pph22 dephosphorylation is graded
such that small changes in PP2A activity can cause
large shifts in Dbf2-mediated Hmt1 activity. Starva-
tion and rapamycin inhibition of TOR activate
Pph22, causing a depletion of CLB2 and delay of M
phase. We propose a general model wherein
changes to Pph22 activity modulate cyclin mRNA
stability to tune cell-cycle progression to environ-
mental conditions.INTRODUCTION
Transcriptional programs and thus messenger RNA (mRNA)
expression patterns constantly adapt to cell-cycle control
mechanisms. We have little understanding, however, of how
posttranscriptional mRNA regulation contributes to the control
of mitosis (Romero-Santacreu et al., 2009). mRNA decay is
modulated by proteins that bind untranslated regions (UTRs) or
open reading frames (ORFs) of mRNA, thereby inducing or pre-
venting their decay. Most mRNA decay machinery is located in
the cytosol (reviewed in Houseley and Tollervey, 2009). Early fac-
tors, such as the heterogeneous nuclear RNA-binding proteins
(hnRNPs), bind cotranscriptionally to mRNA upon posttransla-
tional arginine methylation to promotemRNA export and stability
(Yu et al., 2004). HowmRNA regulation is linked to cell-cycle and
signal-transduction machinery remains the subject of intense
investigation.1080 Cell 153, 1080–1093, May 23, 2013 ª2013 Elsevier Inc.Recently, a mechanism that controls decay of M phase cyclin
CLB2 mRNA was reported in the budding yeast S. cerevisiae
(Trcek et al., 2011). CLB2 mRNA levels increase early in and
then are rapidly degraded at the end of M phase. Trcek et al.
demonstrated that CLB2 transcript decay is regulated by pro-
moter-dependent cotranscriptional recruitment of the mitotic
exit-regulating kinase Dbf2. Other proteins, including hnRNPs,
are recruited to theCLB2 locus topromotemRNAstability andnu-
clearexport.Nospecific links,however, havebeenmadebetween
recruitment of these proteins and Dbf2 activity (Yu et al., 2004).
There is some evidence that starvation-mediated cell-cycle
delaysmay be regulated through control of RNA stability. Starva-
tion is interpreted in part by the TOR pathway, and rapamycin-
induced TOR inhibition mimics the starvation response. G1 cell-
cycle progression is affected by both nitrogen starvation and
rapamycin through reduction ofG1 cyclin transcription and trans-
lation (Barbet et al., 1996). Rapamycin also delays or arrests
different cell-cycle phases, but mechanisms underlying these re-
sponses are unknown (Nakashima et al., 2008). Rapamycin pre-
vents TOR phosphorylation of the substrates protein S6 kinase
and initiation factor (eIF) 4E binding protein 1, resulting in downre-
gulation of translation and accompanying pleotropic effects
(Chungetal., 1992). Interestingly though, theTORpathwaydelays
early M phase progression in a translation-independent manner
(Nakashima et al., 2008). Based on these observations and those
of Trcek et al., we hypothesized that a TOR-regulated pathway
may control M phase cyclin stability posttranscriptionally, via
mechanisms that regulate mRNA decay (Trcek et al., 2011).
Wehavediscoveredapathway that links starvation to control of
CLB2 mRNA stability and M phase delay. Dbf2 phosphorylates
and activates the arginine methyltransferase Hmt1. In turn, Hmt1
methylates hnRNPs, promoting their nuclear localization, their co-
transcriptional association with CLB2 mRNA, and the stability of
CLB2 mRNA. Rapamycin inhibition of TOR or starvation induces
recruitment of the PP2A phosphatase Pph22 to Hmt1, dephos-
phorylation of Hmt1, and simultaneous dissociation of Dbf2 from
Hmt1. Hmt1 is inactivated, preventing methylation of hnRNPs
and thus failure of CLB2mRNA to accumulate in M phase.
RESULTS
Rapamycin Delays Early M Phase
Delayed early M phase was reported for rapamycin treatment
and nutrient starvation (Nakashima et al., 2008). To confirm these
Figure 1. Delays in early M Phase in Rapamycin-Treated and Starved Cells Correlate with Slow Clb2 Accumulations
(A–D) Synchronized cdc15-2 temperature-sensitive mutant strains grown at restrictive temperatures were fixed, and the budded cell proportions (A), metaphase
(B), and anaphase/telophase spindle proportions (C) and DNA content stained with PI (D) measured by microscopy and FACS analysis.
(E) Fluorescent protein-tagged Clb2 quantification was performed for 100 cells in rapamycin and starvation.
Error bars, standard deviation (SD) (n = 100).conclusions, we monitored (1) bud emergence (Figure 1A), (2) bi-
polar metaphase spindle emergence and anaphase/telophase
spindle entry into the bud by Tub1 immunostaining (Figures 1B
and 1C) (St-Pierre et al., 2009), and (3) DNA synthesis by propi-
dium iodide (PI) staining and fluorescence-activated cell sorting
(FACS) detection (Figure 1D). Experiments were performed with
a factor-synchronized cdc15-2 mutant strain at restrictive tem-
perature (i.e., limiting the cell cycle to betweenG1 and telophase)
and treated with or without 200 nM rapamycin. Early M phase
transition was delayed by 30 min in rapamycin, as indicated by
a delay in metaphase spindle emergence compared to control
cells. In contrast, maximal PI DNA staining was observed after
90min, in both conditions, confirming that rapamycin exclusively
causes early M phase delay, not delay in S phase exit.
Rapamycin and Starvation Delay Clb2 Protein Synthesis
We used endogenous cyclin B, Clb2-yellow fluorescent protein
(YFP) fusion to measure protein abundance. Cells were synchro-
nized with a factor, treated with 200 nM rapamycin or control, or
placed in starvation medium, identical to the medium used by
Nakashima et al. (Table S1 available online). Twenty minutes af-
ter a factor release, Clb2-YFP fluorescence was imaged every
10 min for 200 min. We quantified YFP intensities normalized
to cell area for each of 100 cells (Figure 1E). Clb2 synthesis
peaked at 70 and 160 min. In rapamycin or starved cells, how-ever, Clb2 increased slowly, reaching peak intensity at
120 min, consistent with the previously reported M phase delay
in both rapamycin-treated and starved cells (Nakashima et al.,
2008).
CLB2 mRNA Fails to Accumulate in M Phase in
Rapamycin-Treated or Starved Cells
We next determined whether changes in Clb2 protein accu-
mulation were due to transcriptional or posttranscriptional
regulation of CLB2 mRNA. To achieve this, we performed sin-
gle-molecule fluorescence in situ hybridization (FISH) to detect
individual CLB2 and control ACT1 mRNAs in single cells (Trcek
et al., 2011; Zenklusen et al., 2008) (Figure 2A). We also
measured nuclear-localized transcriptional foci to estimate
nascent mRNA numbers, which are affected by initiation rate
and postinitiation, elongation, and termination times for produc-
tion of immature mRNA (Trcek et al., 2011). Cells were synchro-
nized, incubated with rapamycin or in starvation medium 20 min
after a factor release, and fixed every 15 min, and nascent (Fig-
ure 2B) and cytoplasmic mRNA were counted (Figure 2C). Con-
trol cells accumulated up to three nascent CLB2 mRNA mole-
cules in M phase. In starved or rapamycin-treated cells, CLB2
nascent transcript stayed at this maximum for an additional
60 min, consistent with prolonged transcription of CLB2 due to
delayed cell-cycle progression. However, cytosolic CLB2Cell 153, 1080–1093, May 23, 2013 ª2013 Elsevier Inc. 1081
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mRNA remained at basal levels in rapamycin-treated or starved
cells, suggesting posttranscriptional regulation of CLB2 mRNA.
CLB2 Decay Is Mediated by CCR4-NOT and XRN1
Exoribonuclease Activities
Trcek et al. reported that CLB2 mRNA decay is primed with
CLB2 promoter-associated proteins and suggested that regu-
lated mRNA decay implicates the CCR4-NOT complex (Trcek
et al., 2011). Consistent with this hypothesis, we found that
expression of CLB2 transcripts under the ACT1 promoter re-
sulted in unregulated accumulation under all conditions with
the exception of the typical drop in copy number following cell
division (Figure 2D) (Gandhi et al., 2011). ACT1message number
itself does not drop following cell division, typical of what has
been observed in previous studies (Pramila et al., 2006). More-
over, cytoplasmic accumulation is restored in cells lacking
CCR4 and POP2, two components of the CCR4-NOT complex,
revealing a direct role of CCR4-NOT in the regulated decay of
CLB2 mRNA. CLB2 mRNA degradation following CCR4-NOT-
mediated deadenylation may be redundant and achieved by
either 50 to 30 or 30 to 50 degradation, as mutations in either of
the two pathways only marginally affect wild-type (WT) CLB2
mRNA levels (Figures 2E–2H). Furthermore, increases in CLB2
transcripts were identical in both WT strains and those express-
ing the Clb2-YFP fusion (Figure 2I). Finally,CLB2mRNA turnover
in nutrient-starved and rapamycin-treated cells was specific,
since ACT1 transcripts remained constant, with the exception
of the XRN1 mutant.
Rapamycin Causes Sequestering of hnRNPs in the
Nucleus
hnRNP deletions result in decay of cytosolic mRNA or its accu-
mulation in the nucleus (Hector et al., 2002; Kerr et al., 2011).
We thus tested whether rapamycin could induce similar results.
We used diploid strains that express one of each of the endoge-
nous hnRNPsNab2, Npl3, and Hrp1 as green fluorescent protein
(GFP) fusions and endogenous Nup49-dtTomato fusion as a nu-
clear membrane marker. Strains were treated with rapamycin for
6 hr and imaged (Figure 3A). We quantified GFP signal intensities
over the nucleus, the cytoplasm, and the whole cell and normal-
ized the quantity by area for 100 cells (Figure 3B). hnRNP-GFP
signals remained unaffected in the nucleus, but we observed a
significant decrease of cytoplasm fluorescence to autofluores-
cent levels. This rapamycin-induced nuclear sequestration was
specific to the hnRNPs Nab2, Npl3, and Hrp1; no effects were
observed onmRNA export receptor Mex67 or karyopherins (Fig-
ures S1A and S1B). Importantly, an Npl3 mutant that cannot be
arginine methylated did not stabilize CLB2 transcripts. TogetherFigure 2. CLB2 mRNA Fails to Accumulate in Early M Phase in Rapam
(A) cy3.5 CLB2 (in orange) and cy5.0 ACT1 (in red) mRNA probes were combine
accumulation. Cell nuclei were stained with DAPI (in blue). Nascent mRNA chains
(B) Fluorescent CLB2 nascent mRNA counting was performed for 50 cells in rap
(C) Fluorescent CLB2 (left panel) and ACT1 (right panel) mRNA counting was perfo
(D–I) Expression of CLB2 from ACT1 promoter (D), CCR4D (E), POP2D (F), XRN1D
synchronized, and mRNA accumulation was detected with a mixture of cy3.5 CLB
by FISH. Cytoplasmic CLB2 (upper panels) and ACT1 (lower panels) mRNA count
SD (n = 50). Scale bar: 1 mm.these data suggest a direct link between hnRNP methylation,
localization, and CLB2 mRNA decay (Figure 3C) (McBride
et al., 2005).Hmt1 Arginine Methyltransferase Activity Is Abolished
in Rapamycin-Treated Cells
As Hmt1 is the likely candidate for hnRNP arginine methyltrans-
ferase, we tested whether Hmt1 purified from rapamycin-treated
cells could methylate hnRNPs in vitro. We performed a methyl-
ation assay on TAP-tagged purified yeast Nab2 and Npl3 with ra-
diolabeled methyl donor S-adenosyl-L-[methyl-3H]-methionine
(3H-SAM) incubated with purified Hmt1-TAP from strains treated
or not treated with rapamycin for 6 hr. We used western blotting
of the methylation reactions with anti-TAP tag CBP antibody to
verify protein expression and stability of each TAP fusion (Fig-
ure S1C). Both Nab2 and Npl3 were Hmt1 substrates in vitro,
but Hmt1 from rapamycin-treated strains did not methylate
these proteins.Rapamycin Does Not Affect Hmt1 Activity through
Changes in Its Expression or Localization
We used a yeast strain expressing endogenous Hmt1-GFP and
treated or did not treat cells with rapamycin for 6 hr. Hmt1
expression was quantified by FACS (Figure S2A). Surprisingly,
rapamycin-treated cells showed 10-fold increase in Hmt1
expression in the nucleus and cytosol (Figures S2B and S2C).
Thus, rapamycin likely causes a loss in Hmt1 activity, not
expression.Rapamycin Prevents Hmt1 Homo-oligomerization and
Activation
Hmt1 is only active as dimers to hexamers (Weiss et al., 2000).
We tested whether rapamycin prevents Hmt1 oligomerization.
We devised a simple in vivo assay to detect oligomeric states
of Hmt1 based on affinity and immunoaffinity detection of
dual-immunogenic peptide-tagged Hmt1 (Figure 4A). We
generated a diploid reporter strain in which a TAP tag is intro-
duced at one Hmt1 locus and an antigenic mouse dihydrofolate
reductase (DFHR F[3]) is introduced at the second locus.
Following rapamycin treatment, we performed Hmt1-TAP
immunoglobulin G (IgG) immunoprecipitation (IP) (with antibody
against TAP tag protein A domain) and eluted and ran samples
on SDS-PAGE followed by immunoblot with an antibody
against either DHFR F[3] or the TAP CBP domain (Figure 4B).
Under rapamycin treatment, Hmt1-TAP prevented Hmt1-
DHFR F[3] coIP, suggesting that rapamycin prevents Hmt1 olig-
omerization and activation.ycin-Treated and Starved Cells
d to reveal single-cell, single-molecule mRNAs by FISH and to detect mRNA
were estimated from transcriptional foci delimited in the nucleus (arrowhead).
amycin-treated or starved cells. Error bars, SD (n = 50).
rmed for 50 cells in rapamycin-treated or starved cells. Error bars, SD (n = 50).
(G), and SKI2D (H) knockout strains, and W303 and CLB2-YFP (I) strains was
2 and cy5.0 ACT1mRNA probes to reveal single-cell, single-molecule mRNAs
ing was performed for 50 cells in rapamycin-treated or starved cells. Error bars,
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Figure 3. hnRNPs Are Sequestered in the Nuclei of Rapamycin-Treated Cells
(A) hnRNPs fused to GFP-expressing strains (in green) and Nup49 fused to dtTomato-expressing strains (in red; as nuclear membrane marker) were treated with
rapamycin for 6 hr. Cells were imaged and overlaid.
(B) GFP intensities for hnRNPs fused to GFP were quantified and area normalized for 100 cells in rapamycin (in yellow). Segmented GFP signal into nucleus (in
blue) and cytoplasm (in red) is based on nuclear membrane marker. Error bars, SD (n = 100).
(C) Npl3RKmutant strain was synchronized, and mRNA accumulation detected with a mixture of cy3.5CLB2 and cy5.0 ACT1mRNA probes to reveal single-cell,
single-molecule mRNAs by FISH. Cytoplasmic CLB2 (upper panel) and ACT1 (lower panel) mRNA counting was performed for 50 cells in rapamycin-treated or
starved cells. Error bars, SD (n = 50). Scale bar: 1 mm.
See also Figure S1.Hmt1 Oligomerization and Activity Are Ser9
Phosphorylation Dependent
We observed that a fraction of Hmt1 migrated slowly on SDS-
PAGE in the control cells (Hmt1*); this is not observed under ra-
pamycin treatment (Figure 4B). Hmt1* disappeared within 10min
after rapamycin treatment, which corresponds to the time when
Hmt1 oligomer dissociation reaches a steady state as measured
in vivo with the R. reniformis luciferase (Rluc) reporter PCA (Mal-
leshaiah et al., 2010) (Figures 4C and 4D). We reasoned that this
species could be phosphorylated, and phosphorylation could be
required for oligomerization, and thus, we set out to identify po-
tential sites of phosphorylation. A clue was provided by the crys-1084 Cell 153, 1080–1093, May 23, 2013 ª2013 Elsevier Inc.tal structure (Weiss et al., 2000). Hmt1 was crystallized as an
active hexamer. However, the form of Hmt1 used was an N-ter-
minal truncation of 20 amino acids (Weiss et al., 2000). We hy-
pothesized that these residues could contain phosphorylation
sites involved in oligomerization. If these sites are necessary
for Hmt1 oligomerization, they should be conserved. We aligned
Hmt1 homolog sequences for ascomycetes fungi (Figure S2D)
(Lord et al., 2002). Five potential sites were conserved, of which
Ser9 and Tyr23 were the most likely phosphorylate candidates
(NetPhos 2.0) (Blom et al., 1999) (Figure S2E).
We investigated whether Hmt1 hexamerization depends on
Ser9 phosphorylation. We adapted the TAP tag IP assay
Figure 4. Both Hmt1 Low-Mobility Species and Homo-oligomers Are Lost in Rapamycin-Treated Cells
(A) Flow chart of modified TAP tag purification for Hmt1 complexes.
(B) TAP tag purification for Hmt1 complexes was performed for cells treated with rapamycin for 6 hr. For each condition, Hmt1 coIP complex and cell lysates were
analyzed by immunoblotting.
(C) TAP tag purification for Hmt1 fusion proteins by IgG IPs was analyzed by anti-CBP immunoblotting after rapamycin treatments (200 nM).
(D) Time course in vivo dynamic analysis of Hmt1 oligomerization reported by Rluc PCA as a function of time after rapamycin (200 nM) addition to media. PPIs
reported by Rluc PCA were tested for positive control SspBLSLA-SspBYGMF interaction.
Error bars, standard error of the mean (SEM) (n = 3). See also Figure S2.(Figure 5A) to include a step to deplete phosphorylated species
with alkaline phosphatase (AP) following Hmt1-TAP IP. Protein
was applied on IgG resin with AP or vanadate-inactivated AP
for 1 hr (Figure 5B). In vanadate-inactivated AP samples,
Hmt1-TAP IPs copurified with Hmt1-DHFR F[3] but not in sam-
ples with active AP. These results suggest that Hmt1 hexamer
requires phosphorylation of Ser9.
To determine whether Ser9 phosphorylation is required
and sufficient for Hmt1 hexamer, we generated phosphomimetic
(Hmt1S9E) and nonphosphorylatable (Hmt1S9A) mutants.We generated Hmt1 homo-oligomer reporter strains as above
for WT Hmt1 (Hmt1WT-TAP), Hmt1S9E, or Hmt1S9A and
performed our IP assay (Figure 5B). Notably, the Hmt1* species
disappeared from anti-CBP blots of Hmt1S9E-TAP and
Hmt1S9E-TAP, suggesting that Hmt1* does indeed represent a
phosphorylated form of Hmt1 (Figure 5B). Furthermore, we
observed that under AP treatment, Hmt1S9E-TAP copurified
with Hmt1WT-DHFR F[3], which shows that Ser9 phosphomi-
metic mutation is sufficient to hexamerize Hmt1 with dephos-
phorylated Hmt1.Cell 153, 1080–1093, May 23, 2013 ª2013 Elsevier Inc. 1085
(legend on next page)
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In contrast, AP-treatedHmt1S9A-TAP IPs no longer interacted
with Hmt1WT-DHFR F[3], but, interestingly, both Hmt1WT-
DHFR F[3] forms (Hmt1 and Hmt1*) copurified in vanadate-AP-
treated Hmt1S9A-TAP IP. Thus the composition of the IPs is
possibly equal parts Hmt1S9A/Hmt1/Hmt1*, or in other words,
only one in three species need to be phosphorylated to create
Hmt1 oligomers.
We were able to copurify any combination of Hmt1S9A and
Hmt1S9E fused to DHFR F[3] or TAP under AP, with the excep-
tion of Hmt1S9A-TAP IPs failing to copurify Hmt1S9A-DHFR F[3]
under both active and inactive AP treatments, suggesting that
Hmt1 hexamer assembly must begin with a Hmt1*-Hmt1 dimeric
complex.
Finally, we performed the methylation assay described above
with purified Hmt1S9E-TAP or Hmt1S9A-TAP (Figure 5C). Both
purified Nab2 and Npl3 were Hmt1S9E substrates in vitro. How-
ever, Hmt1S9A did not methylate these substrates.
hnRNP Nuclear Export Depends on Hmt1
Phosphorylation
Because Hmt1 methylation promotes hnRNP nuclear export, we
investigated whether Hmt1S9E expression prevents rapamycin-
induced hnRNP nuclear sequestration. We generated strains
harboring an expression vector for WT HMT1 (Hmt1WT) or
HMT1S9E and simultaneously expressed one of each hnRNP
(Nab2, Npl3, and Hrp1) fused to GFP and Nup49-dtTomato as
nuclear membrane marker; strains were imaged and analyzed
as described above (Figure S3A). In rapamycin-treated Hmt1WT
cells, GFP signals for all three hnRNPs were sequestered in the
nucleus, but Hmt1S9E cells showed significant cytoplasmic
signal (Figure 5D). Distributions of other karyopherins were not
affected (Figure S3B).
Hmt1 Phosphorylation State Determines M Phase
Timing
We next tested whether Hmt1 activity affects the timing of the
G2-M transition. We analyzed our cell-cycle markers, as
described above for WT, in Hmt1 mutant strains and scored
onset of budding (Figure 5E), DNA content (Figure S3D), and
metaphase-to-telophase spindle formation (Figures 5F and 5G)Figure 5. Hmt1 Phosphorylation of Ser9 Is Essential and Required for H
mRNA Accumulation and hnRNP Nuclear Export
(A) Flow chart of modified TAP tag purification for Hmt1 complexes with IgG pre
(B) TAP tag purification for Hmt1 complexes from Hmt1-expressing mutant strai
elution of TAP tag protein fusion (lane W), and IgG IPs (lane IP) were analyzed by
(C) Methylation assays were performed with purified TAP-tagged proteins, fractio
and Nab2-TAP were incubated with Hmt1WT-TAP (lane 1), Hmt1S9E-TAP (lane 2
SDS-PAGE, and detected by autoradiography (right panel).
(D) GFP intensities for hnRNPs in Hmt1WT- or Hmt1S9E-overexpressing backg
Cellular GFP signal was further segmented into nucleus (in blue), and cytoplasm (in
(E–G) Hmt1 mutants in cdc15-2 background strains grown at restrictive tempe
telophase spindle proportions (G) were measured.
(H) Hmt1WT, Hmt1S9E, or Hmt1S9A mutant strains were synchronized, treated
imaged, and analyzed similarly to WT strain. Fluorescent nascent mRNA countin
(I) Fluorescent mRNA counting was performed for each time point and distinct stra
(n = 50).
(J) Fluorescent protein-tagged Clb2 quantification was performed for each HMT1
SD (n = 100).
See also Figure S3.(St-Pierre et al., 2009). We integrated HMT1S9E and HMT1S9A
mutations directly into the HMT1 genomic locus in the cdc15-2
strain. We observed an accelerated M phase transition in the
Hmt1S9E strain, independent of rapamycin or nutrient starva-
tion, revealed by early M phase spindle structure emergence
15 min faster than WT cells. Hmt1S9A-expressing cells, in
contrast, showed a 30 min delay in metaphase-anaphase spin-
dle formation, independent of rapamycin treatment and similar
to the rapamycin-induced delay in WT cells. Finally, maximal PI
DNA staining intensities were observed at 90 min in all strains,
confirming that both accelerated and delayed cell-cycle pro-
gression occur exclusively in early M phase, not in S phase.
Hmt1 Phosphorylation Is Required to Regulate CLB2
mRNA Stability
Based on our observations thus far, we hypothesized that star-
vation and rapamycin promote CLB2 mRNA decay through a
mechanism requiring Hmt1 dephosphorylation and disassembly
and loss of methyltransferase activity. This results in nuclear
sequestering of Hmt1 methylation-dependent hnRNPs and a
delay in cell-cycle progression into early M phase. Based on
this hypothesis, we predicted that Hmt1S9E would be active, in-
dependent of rapamycin or starvation, promoting CLB2 mRNA
stability. In contrast, inactive Hmt1S9A would prevent CLB2
mRNA accumulation in M phase. Therefore, as above, we
counted CLB2 nascent and cytoplasmic mRNAs by FISH in
HMT1S9E and HMT1S9A mutant background strains as
described previously (Zenklusen et al., 2008) (Figures 5H, 5I,
S3D, and S3E). The nascent CLB2 mRNA quantities peaked
faster for HMT1S9E versus WT strain and accumulated on
each CLB2 allele within the first 50 min. However, cells express-
ing Hmt1S9A produced a broad CLB2 mRNA wave peaking at
95 min and returning to basal levels at 155 min, independent of
rapamycin or starvation.
Hmt1S9E strain exhibited elevated basal cytosolic CLB2
mRNA throughout the cell cycle, with peaks of copy number
similar to those observed in WT cells. Hmt1S9A strain, however,
failed to accumulate CLB2 mRNA throughout the cell cycle un-
der all conditions. ACT1 mRNA remained constant under all
tested conditions and in all strains (Figure S3D).mt1 Oligomerization, Methyltransferase Activity, and Resulting CLB2
cipitate AP treatments.
ns. For each strain, cell lysates (lane Ly), last washes preceding TEV protease
immunoblotting.
nated on SDS-PAGE, and immunoblotted with anti-CBP (left panel). Npl3-TAP
), or Hmt1S9A-TAP (lane 3) in the presence of [methyl-3H]SAM, fractionated on
round strains were quantified for 100 cells in rapamycin (200 nM) (in yellow).
red) was based on Nup49 nuclear membranemarker. Error bars, SD (n = 100).
rature were fixed, and the budded cell (E) and metaphase (F) and anaphase/
, stained with cy3.5 CLB2 and cy5.0 ACT1 mRNA probes mix (Figure S2A),
g was performed for each time point. Error bars, SD (n = 50).
in for cytosolic CLB2 (left panel) and ACT1 (right panel) mRNAs. Error bars, SD
mutant strain under similar conditions to the those of the WT strain. Error bars,
Cell 153, 1080–1093, May 23, 2013 ª2013 Elsevier Inc. 1087
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Hmt1 Phosphorylation IncreasesClb2 Translation under
Starvation and Rapamycin
Strains expressing Hmt1S9E or Hmt1S9A and Clb2-YFP were
imaged and analyzed as described above (Figure 5J). Clb2 abun-
dance was always elevated in the Hmt1S9E strain, except at 80
and 180min when it was rapidly cleared from cells at mitotic exit.
However, Hmt1S9A strain accumulated Clb2 slowly, 60min after
entering the cell cycle and over a 70 min period, reaching
comparable numbers to control cells. It is thus clear that Hmt1
phosphorylation is required for both CLB2 mRNA decay and
Clb2 protein synthesis.
A Systematic Rapamycin-Dependent Hmt1 PPI Screen
Identifies Potential Kinases and Phosphatases
We thus far determined that hnRNP localization andCLB2mRNA
stability depend on Hmt1 phosphorylation. Next, we used the
DHFR survival-selection protein-fragment complementation
assay (PCA) to identify candidate kinases and phosphatases
that interact with Hmt1 in a rapamycin-dependent manner (Pel-
letier et al., 1998). This assay was used to access the
S. cerevisiae protein-protein interaction (PPI) network for
approximately 92% of its proteins, in vivo and expressed at
endogenous levels (Tarassov et al., 2008). We, performed the
DHFR PCA screen between strains endogenously expressing
Hmt1 fused to DHFR fragment F[1,2] and complementary frag-
ment DHFR F[3] fused to a collection of 5,250 ORFs (Tarassov
et al., 2008). Yeast strains were printed onto plates containing
methotrexate DHFR PCA selective medium and sublethal rapa-
mycin concentration (2 nM). Clones in which an interaction oc-
curs between Hmt1 and another protein result in DHFR folding
from the complementary fragments to which they are fused, re-
sulting in reconstitution of methotrexate-resistant DHFR activity
and thus cell growth and division. Colony-array images were
analyzed to extract pixel intensity per colony in control and rapa-
mycin-treated cells (Table S2). We calculated a fold-change
in interaction for each tested Hmt1 pairwise interaction in rapa-
mycin-treated versus control cells (Figure 6A). Thirty-four Hmt1
protein-protein interactions changed by at least 8-fold. These
proteins were enriched in biological processes such as RNA
30-end processing (p < 106), posttranslational protein modifica-
tion (p < 104), and mRNA processing (p < 103) (Table S2).Figure 6. Dbf2 Kinase and Pph22 Phosphatase Differentially Regulate H
Rapamycin-Treated versus Control Cells
(A) Hmt1 DHFR PCA reporter strains for a collection of 5,250 ORFs were scree
centration (2 nM). Plates were photographed and analyzed, measuring pixel inten
are displayed in a histogram. Strongest rapamycin-induced changes were displa
(B) Hmt1 dimerization reporter strains in PKH2D, DBF2D, PKH3D, and FPR1D and
and cell lysates were analyzed by immunoblotting.
(C) Hmt1-TAP and Dbf2, Pph22, or Hmt1 strains fused to DHFR F[3] or overexpres
For each strain, cell lysates (lane Ly), IgG IPs (lane IP), and last wash (lane W) we
(D) Steady-state-level in vivo analysis of Hmt1, Dbf2, and Pph22 complexes with H
tested for positive control SspBLSLA-SspBYGMF interaction and negative control
Error bars, SEM (n = 3).
(E–G) cdc15-2 background strains expressing Pph22F232S or Dbf2N305A were
telophase (G) spindle proportions were quantified.
(H and I) Pph22F232S- and Dbf2N305A-expressing strains were synchronized,
imaged, and analyzed similarly to theWT strain. Fluorescent nascent (H) and cytop
(J) Fluorescent-tagged Clb2 quantification was performed for Pph22F232S or Db
See also Figure S4 and Table S2.Among these, the hnRNPs Nab2, Npl3, and Hrp1 showed
reduced interaction with Hmt1 in rapamycin-treated reporter
strains, along with several kinases, including Dbf2, Pkh2, and
Pkh3. We also observed rapamycin-induced Hmt1 interaction
with two phosphatases, Nem1 and Pph22, but not Pph22’s pa-
ralog Pph21. We thus next tested whether Hmt1 is a substrate
of these kinases and phosphatases.
Hmt1 Is a Substrate and Regulated by Dbf2 Kinase and
Pph22 Phosphatase
We performed a genetic screen to determine whether any of the
kinases or phosphatases described above could affect Hmt1
oligomerization. We generated Hmt1 dimerization reporter
strains as above in DBF2D, PKH2D, PKH3D, FPR1D knockout
strains under control condition and NEM1D, PPH22D, FPR1D
backgrounds under rapamycin treatment and performed our IP
assay (Figure 6B). The FPR1D strain was insensitive to rapamy-
cin, serving as a control for TOR pathway activation (Heitman
et al., 1991). We observed that Hmt1-TAP phosphorylation and
Hmt1-DHFR F[3] coIP were abolished in the DBF2D strain but
not in PKH2D, PKH3D and FPR1D strains. We repeated the ex-
periments with the phosphatase candidates and found that,
similar to the FPR1D strain, rapamycin-treated PPH22D strains
retained Hmt1-TAP phosphorylation and Hmt1-DHFR F[3]
coIP. These results suggest that Dbf2 and Pph22 are directly
or indirectly essential for Hmt1 phosphorylation and dephos-
phorylation, respectively.
We verified the Dbf2 and Pph22 physical interactions by
Hmt1-TAP IP. We generated strains as above to express
Hmt1WT-TAP and DFHR F[3] fused to Dbf2, Pph22, Hmt1,
and a protein from H. influenzae, SspBLSLA, as negative control
and performed our IP assay with extract from cells treated or
not with rapamycin (200 nM) (Figure 6C). Hmt1-TAP coIP
Dbf2-DHFR F[3] and Hmt1-DHFR F[3] under control conditions
only, and Pph22-DHFR F[3] interacted weakly with Hmt1-TAP
IPs only under rapamycin treatment. These results were spe-
cific for Hmt1, Dbf2, and Pph22 as SspBLSLA-DHFR F[3] did
not IP with Hmt1-TAP under both conditions. These results
and those of the DHFR PCA suggest that both Pph22 and
Dbf2 interact with Hmt1 in rapamycin and control conditions,
respectively.mt1 Phosphorylation State and CLB2 Decay during Early M Phase in
ned on solid-agar DHFR PCA-selective medium at sublethal rapamycin con-
sity over each colony. The protein-protein interaction fold-change distributions
yed for both reduced (in blue) and increased (in red) interactions.
in PPH22D, NEM1D, and FPR1D treated with rapamycin for 6 hr were coIPed,
sing a control SspBLSLA-DHFR F[3] strain were treated with rapamycin for 6 hr.
re analyzed by immunoblotting.
mt1 versus rapamycin reported by Rluc PCA. PPIs reported by Rluc PCA were
, noninteraction of Dbf2-Pph22 and Rluc PCA fragments expressed together.
fixed, and the budded cell proportions (E) and metaphase (F) and anaphase/
treated, stained with a cy3.5 CLB2, ACT1 mRNA probe mixture (Figure S3C),
lasmic (I) mRNA counting was performed for each strain. Error bars, SD (n = 50).
f2N305A mutant strains as done in WT strain. Error bars, SD (n = 100).
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To determine whether Dbf2 kinase could phosphorylate Hmt1
in vitro, we performed a kinase assay for yeast purified Hmt1WT,
Hmt1S9E, and Hmt1S9A with radiolabeled [g-32P]-ATP in the
presence of insect-cell-purified Dbf2-Mob1 or Dbf2N305A-
Mob1 kinase-dead mutant (Mah et al., 2005) (Figure S4A).
Hmt1WT was phosphorylated in vitro by Dbf2-Mob1. Absence
of 32P incorporation for the Dbf2N305-Mob1 kinase-dead
mutant showed that phosphorylation was specific to Dbf2 and
not to a copurified kinase from insect or yeast cells. In contrast,
Hmt1S9E and Hmt1S9A did not incorporate 32P in either kinase
or kinase-dead samples, indicating that Hmt1 can be a direct
Dbf2 substrate and that Ser9 is a unique Dbf2 phosphorylation
site. The sequence around Ser9 is not a consensus for yeast
Dbf2 (R-X-X-S) but is for human homologs (Hao et al., 2008).
Dbf2 Kinase Activity Is Necessary for Hmt1 Activation
To determine whether Dbf2 activity is required for Hmt1 methyl-
transferase activity, we performed the methylation assay as
described above, incubating hnRNPs with purified yeast Hmt1-
TAP from a Dbf2 kinase-dead mutant strain (Figure S4B). In the
absence of Dbf2 kinase activity, Hmt1 did not methylate Npl3
or Nab2. These results confirm that Hmt1 requires phosphoryla-
tion by Dbf2 kinase for its activation.
Hmt1 Oligomerization and Dbf2 Binding to Hmt1 Are
Ultrasensitive to Rapamycin, but Hmt1-Pph22 Binding Is
Graded
We used the Rluc PCA to measure rapamycin dose responses
of Hmt1-Hmt1, Dbf2-Hmt1, and Pph22-Hmt1 interactions
in vivo. Hmt1-Dbf2 and Hmt1-Hmt1 complexes showed ultra-
sensitive dissociation to rapamycin (Hill coefficients of 4.2 ±
0.9 and 3.7 ± 0.8, respectively) and half-maximum effective con-
centrations (EC50) of 37.2 pM and 40.8 pM (Figure 6D). In
contrast, the Pph22-Hmt1 interactionwas graded (Hill coefficient
of 1.3 ± 0.4 and EC50 of 520.0 pM). These dynamicswere specific
as constitutive SspBLSLA-SspBYGMF interaction was insensitive
to rapamycin. Neither Dbf2-Pph22 nor PCA fragments inter-
acted. Dbf2 and Pph22 protein abundances remained constant
over the time course of these experiments, suggesting that
observed rapamycin dose-response behavior was due to active
processes, independent of protein concentration (Figure S4C).
Timing of M Phase Entry Depends on Dbf2 and Pph22
Activities
We tested whether Dbf2 and Pph22 competition for Hmt1 phos-
phorylation affects cell-cycle progression. We analyzed our cell-
cycle markers in synchronized Dbf2 kinase-dead and Pph22
temperature-sensitive mutant strains and scored onset of
budding (Figure 6E), DNA content (Figure S4D), and meta-
phase-to-telophase spindle formation (Figures 6F and 6G) (St-
Pierre et al., 2009). We integrated catalytically dead DBF2N305A
and temperature-sensitive PPH22F232S mutants directly into
DBF2 and PPH22 loci, respectively, in cdc15-2 background
cells. We observed a 30 min delay in early M phase transition
in the Dbf2N305A mutant strain, independent of growth condi-
tions, revealed by metaphase-anaphase spindle emergence.
Under all conditions, however, Pph22F232S-expressing cells
displayed progression similar to that in WT vehicle-treated cells.1090 Cell 153, 1080–1093, May 23, 2013 ª2013 Elsevier Inc.The maximal PI DNA staining was observed after 90 min in all
strains, suggesting that Dbf2 and Pph22 activities affect entry
into M phase not exit from S phase.
Dbf2 Activity Increases and Pph22 Activity Decreases
CLB2 mRNA Stability
We predicted that loss of Dbf2 activity should increase and loss
of Pph22 activity should decrease CLB2 mRNA decay. As
described previously for WT strains, we used FISH in strains
endogenously expressing the Dbf2N305A or Pph22F232S
mutants to count CLB2 nascent and cytoplasmic transcripts
in individual cells (Figures 6H, 6I, S4E, and S4F). We observed
that the Dbf2N305A strain failed to accumulate CLB2
transcripts, even under the control condition. However, the
nascent CLB2 transcripts continued to accumulate, showing
that the mutant has no effect on CLB2 transcription. In contrast,
the Pph22F232S strain grown in rapamycin or starved accumu-
lated nascent and cytoplasmic CLB2 mRNA quantities compa-
rable to the those of the WT strain in the control condition.
Dbf2 and Pph22 Activities Modulate Clb2 Protein
Accumulation
We investigated whether the Dbf2 and Pph22 regulatory activ-
ities on Hmt1 modulate Clb2 protein levels. In DBF2N305A and
PPH22F232S mutant strains expressing Clb2-YFP, we pre-
pared, imaged, and analyzed fluorescence as described above
for the WT strain (Figure 6J). The Dbf2N305A strain accumulated
Clb2 slowly under all conditions, reaching a maximum at
130 min, before being cleared from the cell. In contrast, identical
to conditions seen in control cells, the Pph22F232S strain
showed persistent Clb2 levels under starvation and rapamycin.
DISCUSSION
We propose a general model by which normal cell-cycle pro-
gression or nutrient-dependent early M phase delay is mediated
by phosphorylation-dependent Hmt1 oligomerization and acti-
vation (Figure 7A). We predict that during early M phase, Dbf2
phosphorylates Hmt1 and induces its ultrasensitive assembly
and activation. Active Hmt1methylates hnRNPs, which transport
and stabilize CLB2 transcripts. A feedback loop is propagated
by CLB2 mRNA being translated into B-cyclin, thus associating
with Cdk1 to promote entry into mitosis. Increasing Dbf2 activity
during early M phase further activates, in turn, Hmt1 (Hotz et al.,
2012; Toyn and Johnston, 1994). Simultaneously, activated
PP2A dephosphorylates Hmt1, leading to CLB2 mRNA decay
(Wang and Ng, 2006), leaving fewer transcripts available for B-
cyclin translation. Given the cooperative Hmt1 activation by
Dbf2, versus graded deactivation by Pph22, Dbf2 can activate
Hmt1 if there is only a small decrease in Pph22 activity providing
a means to tune cell-cycle progression.
Our results can explain how early M phase delay may occur in
cells under rapamycin, starvation, or other stresses. It is known
that Pph22 is released from the TAP42 complex when rapamy-
cin-FKBP binds to TOR (Di Como and Arndt, 1996). In our model,
Pph22 promotes the inactive monomerization of Hmt1, resulting
in CLB2 mRNA destabilization and, thus, delay of M phase
entry. This basic circuit could be the target of multiple
Figure 7. Hmt1 Oligomerization-Dependent
Cell-Cycle Regulations
(A) Model of mechanism regulating CLB2 mRNA
decay during early M phase.
(B) Model of Hmt1 phosphorylation-dependent
cooperative oligomerization.stress-responsive kinases and phosphatases. Our genome-
wide screen for Hmt1 revealed protein-protein interactions with
alternative kinases and phosphatases, including the MAP
kinases Pkh2 and Pkh3, which are implicated in cell-wall integrity
(Roelants et al., 2002). These enzymes have been directly impli-
cated inmRNA decay and inclusion in P bodies (Luo et al., 2011).
Both of these phenomena may be mediated, at least in part, by
concerted Pkh2 and Pkh3 association with Hmt1 and ribonu-
cleoprotein complexes during their transport and stabilization.
Furthermore, we observed an interaction with Nem1, a phospha-
tase implicated in nuclear membrane biogenesis and sporulation
in yeast (Enyenihi and Saunders, 2003; Kim et al., 2007).
Our findings are consistent with evidence for Dbf2 roles in
CLB2 transcript decay during early M phase, the associations
of Dbf2, Hmt1, and hnRNPs with gene loci, and their functions
in nuclear export andmRNA stabilization in the cytoplasm (Trcek
et al., 2011; Yu et al., 2004). In apparent contradiction to our re-
sults, Trcek et al. suggested that Dbf2 kinase activity is dispens-
able to CLB2 transcript decay. We can resolve this discrepancy.
Trcek et al. performed their experiments with a different Dbf2 ‘‘ki-
nase-dead’’ mutant. It has, however, been reported that this
mutant has residual kinase activity in vitro (Mah et al., 2005).
We know that the Dbf2 activity during early M phase is minimal,
not peaking until later in M phase (Hotz et al., 2012; Toyn and
Johnston, 1994). We thus argue that the conclusions of TrcekCell 153, 1080–10et al. are correct in that Dbf2 does bind
to the CLB2 locus and regulates mRNA
accumulation, but Dbf2 activity is not
dispensable to mRNA-decay regulation
by hnRNPs.
Hmt1 inactivation does not lead to the
retention of CLB2mRNAs in the nucleus,
but to an acute decay in the cytoplasm.
Thus, methylation of hnRNPs does not
primarily regulate CLB2 mRNA nuclear
export but rather primes the mRNA for
regulation in the cytoplasm (e.g., decay).
Consistent with these observations, two
studies have shown that arginine methyl-
ation by Hmt1 acts as a signal for cotran-
scriptional assembly and hnRNP matura-
tion (Chen et al., 2010; Yu et al., 2004).
Nuclear priming of later mRNA-regulatory
events by cotranscriptional hnRNP as-
sembly is a common step prior to, for
example, the deposition of the exon-
exon junction complex for cytoplasmic
mRNA quality control or assembly of
hnRNPs for cytoplasmic mRNA localiza-
tion (Shen et al., 2010). Presently, we donot know the protein composition of a CLB2 hnRNP complex,
but it is likely that its composition changes as a result of Hmt1
methylation. Consistent with our observation that different
hnRNPs fail to accumulate in the cytoplasm when Hmt1 is in-
hibited, the lack of Nab2, Npl3, and Hrp1 methylation may pre-
vent their binding to CLB2 mRNA. Interestingly, a recent study
showed thatHmt1pactivity is required forNab2andHrp1binding
to the CCR4-NOT complex (Kerr et al., 2011). If methylated Nab2
andHrp1 are part of a stable, cytoplasmicCLB2messenger ribo-
nucleoproteinparticle (mRNP), thismight suggest that interaction
of CCR4-NOT with the CLB2 mRNP is not sufficient to induce
degradation, but that the complex is protected but ‘‘primed’’ for
degradation. Degradation itself may require another signal.
In starved or rapamycin-treated cells, cytosolic mRNA no
longer shows a cyclin increase in copy number, but the steady-
state level remainsconstant, equal to that found inuntreatedcells.
Thus,mRNA remains available for translation, andprotein synthe-
sis continues, albeit at a lower rate. An increase inClb2-YFP levels
without a change inCLB2mRNA levels could be caused by either
an increase of the CLB2mRNA translation and/or an increase in
Clb2 protein stability. Both scenarios are possible; however, as
control of Clb2 protein stability is known to be regulated, this is
the most likely mechanism (Seufert et al., 1995).
We demonstrated that Ser9 is required for Hmt1 phosphoryla-
tion and that oligomerization nucleates unphosphorylated93, May 23, 2013 ª2013 Elsevier Inc. 1091
subunits, resulting in active hexameric Hmt1 complex (Fig-
ure 7B). Thus, only one of three subunits needs to be phosphor-
ylated in order to induce dimers. Our results suggest that the
phosphorylation-dependent dimerization interface allows phos-
phorylated Hmt1 to begin assembly into a dimer. The Hmt1
dimer subsequently assembles with nonphosphorylated sub-
units, resulting in a hexameric complex through a second, phos-
phorylation-independent interaction interface (Weiss et al.,
2000).
Recent studies have demonstrated that the cell-cycle sharp-
ness and coherence are regulated by transcriptional and
biochemical feedback loops that can result in ultrasensitive and
bistable transitions (Holt et al., 2008; Skotheim et al., 2008; Tsai
et al., 2008). The model we describe is a positive feedback loop
in which Dbf2 mediates cooperative Hmt1 assembly, and activa-
tion contributes to the early M phase control and exit from
mitosis. The ultrasensitivity was evident in rapamycin-induced
Dbf2 and Hmt1 disassembly in Hmt1 complexes. This regulatory
design enables a tunable response to stresses that delay the cell
cycle, while maintaining to a near constant the requirement for
Clb2-Cdk1 complex activation to allow cell-cycle progression.
The cooperative assembly and activation of Hmt1 adjust the
rate of Clb2-Cdk1 activity by restrainingCLB2mRNA availability.
These predictions are consistent with the accelerated early M
phase transitions in the constitutively active Hmt1S9E strain.
The constitutively inactive Hmt1S9A mutant simply showed
very lowCLB2mRNA levels with slowClb2 accumulation, result-
ing in early M phase delay. At the same time, the rapamycin
dependence of the Pph22-Hmt1 complex is graded, suggesting
that M phase is set to a critical threshold at whichMphasewill be
delayed if the TOR pathway is downregulated by reduction of nu-
trients. Consistent with this argument, the Pph22mutant resulted
in recovery of a sharp change in CLB2 mRNA accumulation in
early M phase, independent of starvation or rapamycin.
Our results suggest that yeast have evolved a mechanism to
adapt to a nutrient-limited environment by controlling mRNA sta-
bility. The cells thus benefit from an extended early M phase,
allowing them to adapt to starvation by taking the time to synthe-
size thematerials to generate viable daughter cells.We know that
many RNAs, including ribosomal RNAs, other cyclins, and
signaling-protein mRNAs, are under control of hnRNPs and thus
Hmt1 activity (Barbet et al., 1996; Pestov and Shcherbik, 2012;
Yu et al., 2004). Ribosomal RNA synthesis is a limiting factor in
growth, and cyclins and signaling proteins regulate responses to
stresses. It is thus possible that other kinases and phosphatases
that act on Hmt1 respond to different signals, resulting in cell-cy-
cle responses. Finally, Pph22 and Dbf2 are conserved from yeast
to humans, and thus, it would be interesting to explore whether
the same cell-cycle control mechanism is also conserved.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, Growth Conditions, Buffers, and Primers
Tables S1 and S2 describe strains, plasmids, media, and buffers used in this
study, their synchronization protocols, and growth conditions. Primers used
to generate strains and diagnostic primers are listed in Table S4.
Single-Cell, Single-Molecule FISH
Table S4 describes FISH probes used in this study and the FISH procedures.1092 Cell 153, 1080–1093, May 23, 2013 ª2013 Elsevier Inc.FACS Analysis of Strains Expressing GFP-Tagged Proteins
TableS3describes theGFPstrainsused in this studyand theFACSprocedures.
FACS Analysis of Cell DNA Content
Table S3 describes the mutant strains used in this study for PI-stained DNA
content analysis by FACS and the FACS procedures.
Fluorescent Protein Localization
Table S3 describes the GFP strains used in this study and the microscopy
procedures.
Hmt1 DHFR PCA Large-Scale Screen
TheDHFR screen procedures and strains were described previously (Tarassov
et al., 2008). The Hmt1 differential protein interactions (rapamycin versus
ethanol vehicle control) procedures are described in the Extended Experi-
mental Procedures.
TAP-Tagged Protein IP
Table S3 describes the strains expressing TAP-tagged protein used in this
study and the IP procedures.
Hmt1 Methyltransferase Assay
Methyltransferase activity assays are described in the Extended Experimental
Procedures.
Rluc PCA Luminescence Detection
Table S3 describes the Rluc PCA strains used in this study. The Rluc PCA pro-
cedures were described previously (Malleshaiah et al., 2010). Details of the
Hmt1 differential protein interactions (rapamycin versus ethanol vehicle con-
trol) are described in the Extended Experimental Procedures.
Purification of Dbf2-Mob1 Kinase Complex
Dbf2-FLAG was coIPed with Mob1 from Hi5 insect cells as described previ-
ously (Mah et al., 2005) and in the Extended Experimental Procedures.
Protein Kinase Assay
TAP-tagged Hmt1WT, Hmt1S9E, and Hmt1S9A, bound to 20 ml of beads rep-
resenting100 ng of substrate protein, were dialyzed with DKB and incubated
with Dbf2-Mob1 or Dbf2N305A-Mob1 (13 ng of Dbf2 and 2 mCi [g-32P]-ATP)
for 30 min at room temperature. Kinase reactions were stopped by addition of
SDS-PAGE sample buffer, fractionated on SDS-PAGE, and detected by
autoradiography.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and four tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.04.035.
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